Amit Mahipal
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Maintenance Zanzalintinib and Durvalumab in Participants With Advanced Hepatocellular Cancer (NCT07226063) | Amit Mahipal | 2026-05-01 |
Track Amit Mahipal automatically
Every clearance here is in the API, with alerts when new ones post.